ID: ALA5279710

Max Phase: Preclinical

Molecular Formula: C18H16O6

Molecular Weight: 328.32

Associated Items:

Representations

Canonical SMILES:  CC1Oc2cc(O)c3c(=O)c4c(O)ccc(O)c4oc3c2C1(C)C

Standard InChI:  InChI=1S/C18H16O6/c1-7-18(2,3)14-11(23-7)6-10(21)13-15(22)12-8(19)4-5-9(20)16(12)24-17(13)14/h4-7,19-21H,1-3H3

Standard InChI Key:  KIUHCQDWGHJIMP-UHFFFAOYSA-N

Associated Targets(non-human)

Alpha-glucosidase 187 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 328.32Molecular Weight (Monoisotopic): 328.0947AlogP: 3.12#Rotatable Bonds: 0
Polar Surface Area: 100.13Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.11CX Basic pKa: CX LogP: 4.39CX LogD: 4.31
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.43Np Likeness Score: 2.45

References

1. Santos CMM, Freitas M, Fernandes E..  (2018)  A comprehensive review on xanthone derivatives as α-glucosidase inhibitors.,  157  [PMID:30282319] [10.1016/j.ejmech.2018.07.073]

Source